全文获取类型
收费全文 | 87265篇 |
免费 | 7188篇 |
国内免费 | 201篇 |
专业分类
耳鼻咽喉 | 811篇 |
儿科学 | 2126篇 |
妇产科学 | 1754篇 |
基础医学 | 11596篇 |
口腔科学 | 1393篇 |
临床医学 | 9037篇 |
内科学 | 19010篇 |
皮肤病学 | 1073篇 |
神经病学 | 8147篇 |
特种医学 | 3501篇 |
外国民族医学 | 3篇 |
外科学 | 12812篇 |
综合类 | 1343篇 |
一般理论 | 108篇 |
预防医学 | 7875篇 |
眼科学 | 1805篇 |
药学 | 5758篇 |
6篇 | |
中国医学 | 94篇 |
肿瘤学 | 6402篇 |
出版年
2023年 | 520篇 |
2022年 | 882篇 |
2021年 | 2069篇 |
2020年 | 1264篇 |
2019年 | 1843篇 |
2018年 | 2228篇 |
2017年 | 1568篇 |
2016年 | 1698篇 |
2015年 | 1962篇 |
2014年 | 2884篇 |
2013年 | 3619篇 |
2012年 | 5918篇 |
2011年 | 5848篇 |
2010年 | 3305篇 |
2009年 | 2959篇 |
2008年 | 5174篇 |
2007年 | 5365篇 |
2006年 | 5236篇 |
2005年 | 5118篇 |
2004年 | 4688篇 |
2003年 | 4345篇 |
2002年 | 3988篇 |
2001年 | 1501篇 |
2000年 | 1420篇 |
1999年 | 1350篇 |
1998年 | 903篇 |
1997年 | 809篇 |
1996年 | 708篇 |
1995年 | 620篇 |
1994年 | 577篇 |
1993年 | 555篇 |
1992年 | 953篇 |
1991年 | 905篇 |
1990年 | 880篇 |
1989年 | 761篇 |
1988年 | 775篇 |
1987年 | 714篇 |
1986年 | 669篇 |
1985年 | 756篇 |
1984年 | 653篇 |
1983年 | 521篇 |
1982年 | 400篇 |
1981年 | 388篇 |
1980年 | 348篇 |
1979年 | 504篇 |
1978年 | 403篇 |
1977年 | 312篇 |
1976年 | 319篇 |
1974年 | 324篇 |
1973年 | 294篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
Kost-Byerly S Jackson EV Yaster M Kozlowski LJ Mathews RI Gearhart JP 《Journal of pediatric urology》2008,4(4):280-285
ObjectiveReconstruction of bladder exstrophy in newborn infants requires immobilization, sedation and pain management to prevent distracting forces from compromising the repair. We present a 6-year review of our experience.Subjects and methodsWe reviewed the perioperative management of newborn infants undergoing reconstruction between November 1999 and October 2006. Data are presented as means ± SD.ResultsTwenty-three newborn infants underwent surgery under a combined epidural and general anesthetic technique. Tunneled caudal epidural catheters were inserted in all patients and intermittently injected with 0.25% bupivacaine with 1:200,000 epinephrine. Postoperatively, a continuous infusion of 0.1% lidocaine, 0.8–1 mg/kg/h was administered for 15 ± 8 (range 4–30) days. Children were sedated with diazepam for 20 ± 13 (range 2–40) days. Central venous catheters were maintained for 20 ± 9 (range 1–34) days for fluids, drug administration and blood sampling. No patient experienced bladder prolapse or wound dehiscence.ConclusionPerioperative management with tunneled epidural and central venous catheters in newborn infants with bladder exstrophy facilitates immobilization, analgesia and sedation, resulting in an excellent cosmetic repair with no case of bladder prolapse or wound dehiscence. 相似文献
942.
Manuel A.R. Ferreira Judith M. Vonk Hansjörg Baurecht Ingo Marenholz Chao Tian Joshua D. Hoffman Quinta Helmer Annika Tillander Vilhelmina Ullemar Yi Lu Franz Rüschendorf David A. Hinds Norbert Hübner Stephan Weidinger Patrik K.E. Magnusson Eric Jorgenson Lavinia Paternoster 《The Journal of allergy and clinical immunology》2019,143(2):691-699
943.
944.
Barbara H. Johnson Aliki Taylor Gilwan Kim Jennifer Drahos Jiao Yang Mona Akbari Nirav N. Shah 《Biology of blood and marrow transplantation》2019,25(4):834-841
Graft-versus-host disease (GVHD) is the leading cause of nonrelapse mortality among patients who receive allogeneic hematopoietic cell transplantation (allo-HCT). In its acute form (aGVHD), GVHD involves the skin, liver, and gastrointestinal (GI) tract, with GI involvement most strongly associated with poor prognosis. This retrospective cohort study used US healthcare claims data for 2008 to 2015 to identify patients who developed GI aGVHD after allo-HCT performed as curative treatment for hematologic malignancy and compared them with patients who did not develop aGVHD in terms of outcomes related to survival, infections, healthcare resource utilization (HRU), and costs. Whereas the patients without aGVHD saw a 66% improvement in 1-year survival between 2009 and 2015, this effect was not observed in patients with GI aGVHD. Compared with patients without evidence of aGVHD, patients with GI aGVHD were 3.9-fold more likely to develop an infection in the year after allo-HCT. Similarly, patients who developed GI aGVHD were 4.3-fold more likely to have an inpatient admission after allo-HCT discharge, and such an admission cost on average 47% more than an admission for patients without aGVHD. Our findings confirm that GI involvement in aGVHD is associated with higher mortality, risk of infection, HRU, and cost compared with absence of aGVHD. 相似文献
945.
Eric H. Kowalski Diana Kneibner Khalaf Kridin Kyle T. Amber 《Autoimmunity reviews》2019,18(5):526-534
Bullous pemphigoid and pemphigus constitute two major autoimmune blistering diseases (AIBD) with complicated disease pathomechanisms involving a multitude of cytokines and immunological pathways. The purpose of our literature review of the cytokines and chemokines involved in these AIBDs was to allow for a meta-analysis of studies detailing differential cytokine and chemokine changes in these conditions. Elucidation of inflammatory pathways could lead to more targeted therapies, several of which specific monoclonal antibodies already exist and are used safely for other autoimmune diseases. A systematic review of the Pubmed/Medline database was performed for articles characterizing cytokines/chemokines involved in BP and pemphigus. Further, a meta-analysis was carried out using standardized methods, including assessment for heterogeneity. The results of our analysis demonstrated numerous inflammatory alterations in these AIBDs. Significant alterations included serum levels of IL-5, IL-6, IL-8, IL-17, CCL-17, and CCL-26 in patients with BP, and increased blister fluids levels of IL-5, IL-6, IL-8, CCL11, and TNF-α. Blister fluid levels of IL-1α are decreased in BP. In pemphigus, we identified significantly increased serum levels of IL-10, IL-17, and CCL17. We have additionally summarized all studies excluded from meta-analysis to provide a comprehensive summary of cytokine/chemokine alterations in these two conditions. 相似文献
946.
947.
Taylor Morrisette Amanda G. Van Matre Matthew A. Miller Scott W. Mueller Valida Bajrovic Maheen Z. Abidi Esther Benamu Jeffrey N. Kaiser Gerard R. Barber Stephanie Chase Jennifer Tobin Douglas N. Fish Jonathan A. Gutman 《Biology of blood and marrow transplantation》2019,25(10):2091-2097
Clostridioides difficile infection (CDI) is a common complication in the hematopoietic stem cell transplantation (HSCT) and hematologic malignancy (HM) population. CDI is associated with increased hospital length of stay, health care and societal costs, morbidity, and mortality. Identifying strategies for secondary prevention of CDI is of extreme importance in the HSCT/HM population. In this study, our primary objective was to evaluate the effectiveness and safety of an oral vancomycin prophylaxis (OVP) protocol for secondary prevention of CDI in a retrospective cohort of adult autologous/allogeneic HSCT recipients and patients with HM who did not undergo HSCT with a first CDI episode treated with concomitant broad-spectrum antibiotics (BSA). Patients were diagnosed and treated for CDI as inpatients and/or outpatients and were divided into 2 groups based on a preprotocol versus postprotocol analysis: the OVP group, comprising patients who received planned monotherapy with oral vancomycin 125 mg every 6 hours for 14 days for a first episode of CDI and subsequently received OVP posttreatment and a no OVP (NOVP) group, comprising patients who received planned monotherapy with oral vancomycin 125 mg every 6 hours for 14 days for a first episode of CDI and subsequently did not receive OVP posttreatment. OVP was defined as vancomycin 125 mg every 12 hours for up to 7 days after BSA discontinuation. The primary endpoint was recurrent CDI (rCDI), defined as symptoms of loose stools/diarrhea with high clinical suspicion for CDI prompting empiric therapy within 60 days of completion of treatment/prophylaxis for the first CDI episode. The incidence of vancomycin-resistant enterococcal (VRE) infection and 60-day mortality were also compared between the 2 groups. Multivariate logistic regression was created from associated variables to identify independent associations with rCDI. A total of 50 patients were included, 21 in the OVP group (42%) and 29 in the NOVP group (58%). The mean patient age was 58 years, and the cohort was 60% male and 86% Caucasian. HSCT was performed in 60% of the patients, and 76% of CDI cases were diagnosed during hospitalization. The rate of rCDI was significantly lower in the OVP group compared with the NOVP group (5% [1 of 21] versus 35% [10 of 29]; P= .016), with no subsequent increase in VRE infection rate (14% [3 of 21] versus 10% [3 of 29]; P = .686). By multivariable logistic regression, rCDI was inversely associated with OVP (odds ratio [OR], .14; 95% confidence interval [CI], .007 to .994; P = .049) and directly associated with outpatient CDI diagnosis (OR, 8.72; 95% CI, 1.816 to 49.158; P = .007). No between-group differences were found in 60-day mortality (10% [2 of 21] for OVP versus 7% [2 of 29] for NOVP; P > 0.999). OVP appears to be safe and effective for secondary prevention of CDI in the HSCT/HM population. Prospective trials are needed to validate the effectiveness of OVP in this vulnerable population to prevent rCDI. 相似文献
948.
Natalie M. Gallant Kathryn E. Singh Candida Brown Virginia Kimonis Eric A. Muller II 《American journal of medical genetics. Part A》2019,179(3):498-502
ALG11‐Congenital Disorder of Glycosylation (ALG11‐CDG, also known as congenital disorder of glycosylation type Ip) is an inherited inborn error of metabolism due to abnormal protein and lipid glycosylation. We describe two unrelated patients with ALG11‐CDG due to novel mutations, review the literature of previously described affected individuals, and further expand the clinical phenotype. Both affected individuals reported here had severe psychomotor disabilities and epilepsy. Their fibroblasts synthesized truncated precursor glycan structures, consistent with ALG11‐CDG, while also showing hypoglycosylation of a novel biomarker, GP130. Surprisingly, one patient presented with normal transferrin glycosylation profile, a feature that has not been reported previously in patients with ALG11‐CDG. Together, our data expand the clinical and mutational spectrum of ALG11‐CDG. 相似文献
949.
Danielle K. Bourque Mireille Cloutier Kristin D. Kernohan Eric Bareke David Grynspan Jean Michaud CareRare Canada Consortium Kym M. Boycott 《American journal of medical genetics. Part A》2019,179(5):813-816
Neu–Laxova syndrome (NLS) is a lethal autosomal recessive microcephaly syndrome associated with intrauterine growth restriction (IUGR) and multiple congenital anomalies. Clinical features include central nervous system malformations, joint contractures, ichthyosis, edema, and dysmorphic facial features. Biallelic pathogenic variants in either the PHGDH or PSAT1 genes have been shown to cause NLS. Using exome sequencing, we aimed to identify the underlying genetic diagnosis in three fetuses (from one family) with prenatal skin edema, severe IUGR, micrognathia, renal anomalies, and arthrogryposis and identified a homozygous c.1A>C (p.Met1?, NM_006623.3) variant in the PHGDH gene. Loss of the translation start codon is a novel genetic mechanism for the development of NLS. Prenatal diagnosis of NLS is challenging and few reports describe the fetal pathology. Fetal neuropathologic examination revealed: delayed brain development, congenital agenesis of the corticospinal tracts, and hypoplasia of the hippocampus, cerebellum and brainstem. Each pregnancy also showed increased nuchal translucency (NT) or cystic hygroma. While NLS is rare, it may be a cause of recurrent increased NT/cystic hygroma. This finding provides further support that cystic hygroma has many different genetic causes and that exome sequencing may shed light on the underlying genetic diagnoses in this group of prenatal patients. 相似文献
950.
Saeed Jerban Yajun Ma Lidi Wan Adam C. Searleman Hyungseok Jang Robert L. Sah Eric Y. Chang Jiang Du 《NMR in biomedicine》2019,32(2)
Intracortical bone porosity is a key microstructural parameter that determines bone mechanical properties. While clinical MRI visualizes the cortical bone with a signal void, ultrashort echo time (UTE) MRI can acquire high signal from cortical bone, thus enabling quantitative assessments. Magnetization transfer (MT) imaging combined with UTE‐MRI can indirectly assess protons in the bone collagenous matrix, which are inversely related to porosity. This study aimed to examine UTE‐MT MRI techniques to evaluate intracortical bone porosity. Eighteen human cortical bone specimens from the tibial and fibular midshafts were scanned using UTE‐MT sequences on a clinical 3 T MRI scanner and on a high‐resolution micro‐computed tomography (μCT) scanner. A series of MT pulse saturation powers (500°, 1000°, 1500°) and frequency offsets (2, 5, 10, 20, 50 kHz) were used to measure the macromolecular fraction (MMF) and macromolecular T2 (T2MM) using a two‐pool MT model. The measurements were made on 136 different regions of interest (ROIs). ROIs were selected at three cortical bone layers (from endosteum to periosteum) and four anatomical sites (anterior, mid‐medial, mid‐lateral, and posterior) to provide a wide range of porosity. MMF showed moderate to strong correlations with intracortical bone porosity (R = ?0.67 to ?0.73, p < 0.01) and bone mineral density (BMD) (R = +0.46 to +0.70, p < 0.01). Comparing the average MMF between cortical bone layers revealed a significant increase from the endosteum towards the periosteum. Such a pattern was in agreement with porosity reduction and BMD increase towards the periosteum. These results suggest that the two‐pool UTE‐MT technique can potentially serve as a novel and accurate tool to assess intracortical bone porosity. 相似文献